These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7401721)

  • 1. Therapeutic significance of the drug lag.
    Daniels CE; Wertheimer AI
    Med Care; 1980 Jul; 18(7):754-65. PubMed ID: 7401721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug lag '80: the missing medicines.
    Rhein RW
    Med World News; 1980 Sep; 21(18):31-48. PubMed ID: 10317008
    [No Abstract]   [Full Text] [Related]  

  • 3. Despite curbing new drug shortages, shortfall of drugs a persistent problem.
    Kuehn BM
    JAMA; 2013 Feb; 309(6):532-3. PubMed ID: 23403656
    [No Abstract]   [Full Text] [Related]  

  • 4. Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007.
    Meron D
    Seton Hall Law Rev; 2007; 37(4):929-39. PubMed ID: 18363219
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug shortage crisis resolution.
    Duffy E
    J Pharm Pract; 2012 Dec; 25(6):619-20. PubMed ID: 23222856
    [No Abstract]   [Full Text] [Related]  

  • 6. Senator proposes drug shortages law.
    Thompson CA
    Am J Health Syst Pharm; 2011 Mar; 68(6):461. PubMed ID: 21378289
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug shortages undergo more scrutiny by Congress.
    Thompson CA
    Am J Health Syst Pharm; 2012 Mar; 69(6):446, 448, 450. PubMed ID: 22382473
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs of limited commercial value.
    Finkel MJ
    N Engl J Med; 1980 Mar; 302(11):643-4. PubMed ID: 7351925
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug development, regulation, and the practice of medicine.
    Wardell WM
    JAMA; 1974 Sep; 229(11):1457-61. PubMed ID: 4408186
    [No Abstract]   [Full Text] [Related]  

  • 10. Report suggests steps to improve safety of drug supply.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1570, 1574. PubMed ID: 21856799
    [No Abstract]   [Full Text] [Related]  

  • 11. US drug shortages are set to reach record high in 2011, report says.
    Tanne JH
    BMJ; 2011 Dec; 343():d8307. PubMed ID: 22194406
    [No Abstract]   [Full Text] [Related]  

  • 12. Restricting channels of distribution for pharmaceuticals.
    Fink JL
    Am Pharm; 1983 Jul; NS23(7):26-30. PubMed ID: 6613846
    [No Abstract]   [Full Text] [Related]  

  • 13. Stakeholders in supply chain discuss shortages.
    Thompson CA
    Am J Health Syst Pharm; 2011 Jan; 68(1):9-10. PubMed ID: 21164058
    [No Abstract]   [Full Text] [Related]  

  • 14. Looking for the treatment for drug shortages: not a simple prescription.
    Berry AJ
    Mayo Clin Proc; 2014 Mar; 89(3):281-3. PubMed ID: 24582186
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical regulations in the 1980s--predictions.
    Halperin JA
    Drug Intell Clin Pharm; 1982 Apr; 16(4):320-4. PubMed ID: 7040027
    [No Abstract]   [Full Text] [Related]  

  • 16. Time and money: an analysis of the legislative efforts to address the prescription drug shortage crisis in America.
    Born K
    J Leg Med; 2012 Apr; 33(2):235-51. PubMed ID: 22694095
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

  • 18. The Food and Drug Administration's requirements for approval of new dental drugs.
    Gilkes CC
    Symp Pharmacol Ther Toxicol Group; 1975 Apr; ():5-12. PubMed ID: 1064180
    [No Abstract]   [Full Text] [Related]  

  • 19. The drug lag issue: the debate seen from an international perspective.
    Andersson F
    Int J Health Serv; 1992; 22(1):53-72. PubMed ID: 1735628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
    Poser S
    Food Drug Law J; 2007; 62(4):653-94. PubMed ID: 18557225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.